Boceprevir

Drugs in R and D - United Kingdom
doi 10.1007/bf03259789
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors

Unknown

Publisher

Springer Nature

Related search

Boceprevir in the Treatment of Chronic Hepatitis C Virus Infection

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

Development and Validation of Stability-Indicating HPLC Method for Determination of Boceprevir

International Research Journal of Pharmacy
2016English

Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C: Safety Management in Clinical Practice

Liver International
Hepatology
2011English

CPC-107 Pharmacotherapy Follow-Up in Chronic Hepatitis C Patients Treated With Boceprevir or Telaprevir

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

PGI39 Budegt Impact Analysis of HCV Therapy Cost After Boceprevir Addition to Standard Therapeutic Regime

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-Infected Persons: AIDS Clinical Trials Group Study A5309s

Drugs in R and D
Pharmacology
2017English

GRP-041 Collection and Analysis of Adverse Effects and Co-Medications for Outpatients Receiving Boceprevir- Or Telaprevir-Based Treatment for Chronic Hepatitis C

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

The Discovery and Development of Boceprevir: A Novel, First-Generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease

Journal of Clinical and Translational Hepatology
2013English

Análise De Custo-Efetividade Do Tratamento Da Hepatite C Crônica Genótipo 1: Comparação Da Adição Do Boceprevir a Terapia Padrão (Interferon-Α Peguilado E Ribavirina)

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy